Inventor
GREGORIADIS GREGORY
GB44 patents
⚠️ This page may combine multiple inventors who share the name “GREGORIADIS GREGORY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIPOXEN TECHNOLOGIES LTD
15 patentsUS7384923B2Jun 10, 2008
Liposomes
LIPOXEN TECHNOLOGIES LTD55 citations98
US8796207B2Aug 5, 2014
Derivatisation of erythropoietin (EPO)
LIPOXEN TECHNOLOGIES LTD6 citations92
US7807824B2Oct 5, 2010
Sialic acid derivatives for protein derivatisation and conjugation
LIPOXEN TECHNOLOGIES LTD14 citations92
US7790696B2Sep 7, 2010
Cationic liposomes containing immune response generating moieties
LIPOXEN TECHNOLOGIES LTD26 citations92
US8981050B2Mar 17, 2015
N-terminal derivatisation of proteins with polysaccharides
LIPOXEN TECHNOLOGIES LTD5 citations84
US7381421B2Jun 3, 2008
Liposomes
LIPOXEN TECHNOLOGIES LTD9 citations84
US7691826B2Apr 6, 2010
Polysialic acid derivatives
LIPOXEN TECHNOLOGIES LTD8 citations83
US6962972B2Nov 8, 2005
Derivatization of proteins
LIPOXEN TECHNOLOGIES LTD9 citations74
US8933026B2Jan 13, 2015
Derivatisation of erythropoietin (EPO)
LIPOXEN TECHNOLOGIES LTD2 citations73
US7008791B1Mar 7, 2006
Liposome-entrapped DNA oral vaccines
LIPOXEN TECHNOLOGIES LTD8 citations66
US9040478B2May 26, 2015
Derivatisation of granulocyte colony-stimulating factor
LIPOXEN TECHNOLOGIES LTD1 citations63
US9266936B2Feb 23, 2016
Derivatisation of erythropoietin (EPO)
LIPOXEN TECHNOLOGIES LTD1 citations62
US9234020B2Jan 12, 2016
Derivatisation of erythropoietin (EPO)
LIPOXEN TECHNOLOGIES LTD0 citations62
US9102714B2Aug 11, 2015
Polysialic acid derivatives
LIPOXEN TECHNOLOGIES LTD2 citations62
US8946406B2Feb 3, 2015
Derivatisation of erythropoietin (EPO)
LIPOXEN TECHNOLOGIES LTD0 citations62
LIPOXEN TECH LTD
9 patentsUS9492556B2Nov 15, 2016
N-terminal derivatisation of proteins with polysaccharides
LIPOXEN TECH LTD4 citations84
US9452224B2Sep 27, 2016
Sialic acid derivatives for protein derivatisation and conjugation
LIPOXEN TECH LTD3 citations72
US9789163B2Oct 17, 2017
N-terminal derivatisation of proteins with polysaccharides
LIPOXEN TECH LTD0 citations62
US9579393B2Feb 28, 2017
Derivatisation of erythropoietin (EPO)
LIPOXEN TECH LTD0 citations62
US9549990B2Jan 24, 2017
Derivatisation of erythropoietin (EPO)
LIPOXEN TECH LTD0 citations62
US9492557B2Nov 15, 2016
Derivatisation of granulocyte colony-stimulating factor
LIPOXEN TECH LTD0 citations62
US9474805B2Oct 25, 2016
Derivatisation of granulocyte colony-stimulating factor
LIPOXEN TECH LTD0 citations62
US9750692B2Sep 5, 2017
Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
LIPOXEN TECH LTD1 citations51
US9486510B2Nov 8, 2016
Method to enhance an immune response of nucleic acid vaccination
LIPOXEN TECH LTD0 citations51
JAIN SANJAY
6 patentsUS8394921B2Mar 12, 2013
N-terminal derivatisation of proteins with polysaccharides
JAIN SANJAY6 citations92
US8299026B2Oct 30, 2012
Derivatisation of erythropoietin (EPO)
JAIN SANJAY9 citations92
US8299015B2Oct 30, 2012
Derivatisation of granulocyte colony-stimulating factor
JAIN SANJAY6 citations92
US9795683B2Oct 24, 2017
Glycopolysialylation of non-blood coagulation proteins
JAIN SANJAY3 citations70
US8653255B2Feb 18, 2014
Sialic acid derivatives for protein derivatisation and conjugation
JAIN SANJAY3 citations62
US9212232B2Dec 15, 2015
Reduction of endotoxin in polysialic acids
JAIN SANJAY0 citations52
LIPOXEN TECH LIMITED
4 patentsUS10406209B2Sep 10, 2019
Sialic acid derivatives for protein derivatisation and conjugation
LIPOXEN TECH LIMITED0 citations51
US10301396B2May 28, 2019
Reduction of endotoxin in polysialic acids
LIPOXEN TECH LIMITED0 citations51
US9920137B2Mar 20, 2018
Polysialic acid derivatives
LIPOXEN TECH LIMITED0 citations51
US10772968B2Sep 15, 2020
Glycopolysialylation of non-blood coagulation proteins
LIPOXEN TECH LIMITED0 citations48
SECR DEFENCE BRIT
3 patentsBACON ANDREW DAVID
3 patentsUS8828405B2Sep 9, 2014
Method to enhance an immune response of nucleic acid vaccination
BACON ANDREW DAVID2 citations60
US8075896B2Dec 13, 2011
Method to enhance an immune response of nucleic acid vaccination
BACON ANDREW DAVID2 citations60
US8753647B2Jun 17, 2014
Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
BACON ANDREW DAVID1 citations49